Citations

Clear

6274 citation(s) found for "To, Andrew".

Clinical and Kidney Structural Characteristics of Living Kidney Donors With Nephrolithiasis and Their Long-term Outcomes
D’Costa, Matthew R., Merzkani, Massini A., Denic, Aleksandar, Mullan, Aidan F., Larson, Joseph J., Kremers, Walter K., Park, Walter D., Alexander, Mariam P., Chakkera, Harini A., Taler, Sandra J., Erickson, Stephen B., Stegall, Mark D., Issa, Naim, Rule, Andrew D., Kremers, Walter K. , Đenić, Aleksandar , Chakkera, Harini A. , D’Costa, Matthew R. , Erickson, Stephen J, D'Costa, Matthew , Denic, Aleksandar , Chakkera, Harini A , Kremers, Walter K , Merzkani, Massini A., Mullan, Aidan F., Larson, Joseph J., Park, Walter D., Alexander, Mariam P., Taler, Sandra J., Erickson, Stephen B., Stegall, Mark D., Issa, Naim, Rule, Andrew D.

Mayo Clinic

Transplantation Direct | February 1, 2022 | Volume: 8 | Issue: 1 | Pages: e1278

10.1097/txd.0000000000001278 | PMID 34966845 Get It

Background. Nephrolithiasis in living kidney donors is concerning due to the potential impact on long-term postdonation kidney function. Methods. We performed a cohort study of living kidney donors from 2 centers with a baseline computed tomography scan and implantation renal biopsy. Donors (>5 y since donation) completed a follow-up survey or underwent chart review to assess eGFR and incident hypertension. Stone formers were classified as symptomatic if they had a past symptomatic episode or asymptomatic if only incidental radiographic kidney stones were identified during donor evaluation. We compared baseline clinical, imaging, and biopsy characteristics by stone former status including review of metabolic evaluations in stone formers. Long-term risks of renal complications (low eGFR and hypertension) by stone former status were evaluated. Results. There were 12 symptomatic and 76 asymptomatic stone formers among 866 donors. Overall, baseline clinical characteristics and implantation biopsy findings were similar between stone formers and non-stone formers. After a median follow-up of 10 y, stone former status was not associated with eGFR <60 mL/min/1.73 m2, eGFR <45 mL/min/1.73 m2, or hypertension. Conclusions. Both asymptomatic and symptomatic SF have favorable histology findings at baseline. Long-term kidney outcomes were favorable in select stone formers with no evident increased long-term risk for decreased kidney function or hypertension after donation.
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk
Li, Yafang , Xiao, Xiangjun , Cheng, Chao , McKay, James , Lam, Stephen , Tardón, Adonina , Chen, Chu, Bojesen, Stig E. , Landi, Maria Teresa , Risch, Angela , Wichmann, H‐Erich, Rennert, Gad , Goodman, Gary E. , Field, John K. , Davies, Michael P.A. , Shete, Sanjay , Melander, Olle , Brunnström, Hans , Hung, Rayjean J, Andrew, Angeline S. , Shen, Hongbing , Zienolddiny, Shan, Grankvist, Kjell , Johansson, Mikael , Caporaso, Neil E. , Aldrich, Melinda C. , Schwartz, Ann G. , Gorlov, Ivan P. , Purrington, Kristen S. , Bailey‐Wilson, Joan E. , Mandal, Diptasri , Willey, James C. , Gaba, Colette , Brennan, Paul , Hung, Rayjean J. , Rennert, Gad , Cheng, Chao , Wilson, Richard K , Hung, Rayjean J , Field, John K , Tardón, Adonina , Davies, Michael P A , Bojesen, Stig E , Risch, Angela , Grankvist, Kjell , Purrington, Kristen S , Willey, James C , Shen, Hongbing , Li, Jianrong , Byun, Jinyoung , Bossé, Yohan , Albanes, Demetrius , Johansson, Mattias , Bickeböller, Heike , Christiani, David C. , Arnold, Susanne M. , Marchand, Loı̈c Le , Liu, Geoffrey , Kiemeney, Lambertus A. , Sun, Ryan , Teare, M. Dawn , Hong, Yun‐Chul , Lazarus, Philip J. , Schabath, Matthew B. , Yang, Ping , Liu, Yanhong , Han, Younghun , Pinney, Susan M. , Amos, Christopher I.

Mayo Clinic

Human Molecular Genetics | February 1, 2022 | Volume: 31 | Issue: 16 | Pages: 2831-2843

10.1093/hmg/ddac030 | PMID 35138370 Get It

Abstract Differences by sex in lung cancer incidence and mortality have been reported which cannot be fully explained by sex differences in smoking behavior, implying existence of genetic and molecular basis for sex disparity in lung cancer development. However, the information about sex dimorphism in lung cancer risk is quite limited despite the great success in lung cancer association studies. By adopting a stringent two-stage analysis strategy, we performed a genome-wide gene–sex interaction analysis using genotypes from a lung cancer cohort including ~ 47 000 individuals with European ancestry. Three low-frequency variants (minor allele frequency &lt; 0.05), rs17662871 [odds ratio (OR) = 0.71, P = 4.29×10−8); rs79942605 (OR = 2.17, P = 2.81×10−8) and rs208908 (OR = 0.70, P = 4.54×10−8) were identified with different risk effect of lung cancer between men and women. Further expression quantitative trait loci and functional annotation analysis suggested rs208908 affects lung cancer risk through differential regulation of Coxsackie virus and adenovirus receptor gene expression in lung tissues between men and women. Our study is one of the first studies to provide novel insights about the genetic and molecular basis for sex disparity in lung cancer development.
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey
Harkins, R. Andrew , Patel, Sharvil , Lee, Michelle J. , Switchenko, Jeffrey M. , Ansell, Stephen M. , Bartlett, Nancy L. , Blum, Kristie A. , Cashen, Amanda F. , Casulo, Carla , Friedberg, Jonathan W. , Johnston, Patrick B. , Leonard, John P. , Link, Brian K. , Lossos, Izidore S. , Martin, Peter , Maurer, Matt, Mehta–Shah, Neha , Koff, Jean L. , Flowers, Christopher R. , Patel, Sharvil P , Kahl, Brad S , Link, Brian K , Lossos, Izidore S , Maurer, Matthew , Mehta-Shah, Neha , Westin, Jason R , Koff, Jean L , Bartlett, Nancy L , Switchenko, Jeffrey , Casulo, Carla , Kahl, Brad S. , Reagan, Patrick Michael , Westin, Jason R.

Mayo Clinic

Blood Advances | January 31, 2022 | Volume: 6 | Issue: 9 | Pages: 2745-2756

10.1182/bloodadvances.2021006504 | PMID 35100356 Get It

Abstract Recent first-line randomized controlled trials (RCTs) for patients with diffuse large B-cell lymphoma (DLBCL) have shown negative results, which may be due in part to onerous eligibility criteria limiting enrollment of poor-risk patients who require immediate treatment. We conducted a Delphi-method survey with lymphoma experts in the United States to define recommendations for essential and potentially unnecessary enrollment criteria for modern first-line DLBCL RCTs aimed at increasing clinical diversity of ensuing study groups. We first tabulated enrollment criteria from 19 DLBCL RCTs spanning the rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) era to identify common eligibility criteria from prior DLBCL RCTs for inclusion in the Delphi-method survey. We tabulated 451 total eligibility criteria comprising 51 criterion categories across 19 first-line DLBCL RCTs in the R-CHOP era. We then surveyed lymphoma clinical trial experts representing 8 academic medical centers in the United States regarding essential and unnecessary eligibility criteria for modern DLBCL RCTs. Seventeen of 29 invited clinical investigators completed the round-1 questionnaire (response rate, of 58.6%), 15 of 17 round-1 participants (88.2%) completed the round-2 survey, and all round-1 participants reviewed finalized recommendations for eligibility criteria for modern first-line DLBCL RCTs. We defined consensus recommendations for 31 modernized eligibility criteria including threshold values for 10 quantitative eligibility criteria aimed at facilitating enrollment of a clinically diverse study population in first-line DLBCL RCTs designed to improve standard-of-care therapy.
Disparities in Hypoxemia Detection by Pulse Oximetry Across Self-Identified Racial Groups and Associations With Clinical Outcomes*
Henry, Nicole , Hanson, Andrew C. , Schulte, Phillip J. , Manento, Megan N., Weister, Timothy J. , Henry, Nicole R, Warner, Nafisseh S. , Warner, Matthew A.

Mayo Clinic

Critical Care Medicine | January 31, 2022 | Volume: 50 | Issue: 2 | Pages: 204-211

10.1097/ccm.0000000000005394 | PMID 35100193 Get It

OBJECTIVES: To assess disparities in hypoxemia detection by pulse oximetry across self-identified racial groups and associations with clinical outcomes. DESIGN: Observational cohort study from May 5, 2018, to December 31, 2020. SETTING: Three academic medical centers in the United States. PATIENTS: Adults greater than or equal to 18 years who self-identified as White, Black, Asian, or American Indian admitted to the ICU or undergoing surgery during inpatient hospitalization with simultaneous measurements of pulse oximetry-estimated oxygen saturation and arterial blood gas-derived oxygen saturation. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Multivariable models were employed to assess the relationships between race, occult hypoxemia (i.e., arterial blood gas-derived oxygen saturation < 88% despite pulse oximetry-estimated oxygen saturation ≥ 92%), and clinical outcomes of hospital mortality and hospital-free days. One-hundred twenty-eight–thousand two-hundred eighty-five paired pulse oximetry-estimated oxygen saturation–arterial blood gas-derived oxygen saturation measurements were included from 26,603 patients. Pulse oximetry-estimated oxygen saturation on average overestimated arterial blood gas-derived oxygen saturation by 1.57% (1.54–1.61%). Black, Asian, and American Indian patients were more likely to experience occult hypoxemia during hospitalization (estimated probability 6.2% [5.1–7.6%], 6.6% [4.9–8.8%], and 6.6% [4.4–10.0%], respectively) compared with White patients (3.6% [3.4–3.8%]). Black patients had increased odds of occult hypoxemia compared with White patients after adjustment (odds ratio, 1.65; 1.28–2.14; p < 0.001). Differences in occult hypoxemia between Asian and American Indian patients compared with White patients were not significant after adjustment (odds ratio, 1.53; 0.95–2.47; p = 0.077 and odds ratio, 1.31; 0.80–2.16; p = 0.288, respectively). Occult hypoxemia was associated with increased odds of mortality in surgical (odds ratio, 2.96; 1.20–7.28; p = 0.019) and ICU patients (1.36; 1.03–1.80; p = 0.033). Occult hypoxemia was associated with fewer hospital-free days in surgical (–2.5 d [–3.9 to –1.2 d]; p < 0.001) but not ICU patients (0.4 d [–0.7 to 1.4 d]; p = 0.500). CONCLUSIONS: Occult hypoxemia is more common in Black patients compared with White patients and is associated with increased mortality, suggesting potentially important outcome implications for undetected hypoxemia. It is imperative to validate pulse oximetry with expanded racial inclusion.
Long-Term Follow-Up of Fractional CO2 Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer Survivors
Quick, Allison , Hundley, Andrew F., Evans, Cynthia, Stephens, Julie , Ramaswamy, Bhuvaneswari , Reinbolt, Raquel E. , Deusen, Jeffrey Bryan Van, Williams, Nicole , Sardesai, Sagar , Loprinzi, Charles L. , Lustberg, Maryam B. , Quick, Allison M , Lustberg, Maryam , Noonan, Anne M. , Deusen, Jeff Van, Wesolowski, Robert , Stover, Daniel G. , Faubion, Stephanie S.

Mayo Clinic

Journal of Clinical Medicine | January 31, 2022 | Volume: 11 | Issue: 3 | Pages: 774

10.3390/jcm11030774 | PMID 35160226 Get It

(1) Background: The objective of this study was to determine the long-term efficacy of fractional CO2 laser therapy in breast cancer survivors. (2) Methods: This was a single-arm study of breast cancer survivors. Participants received three treatments of fractional CO2 laser therapy and returned for a 4 week follow-up. Participants were contacted for follow-up at annual intervals. The Vaginal Assessment Scale (VAS), the Female Sexual Function Index (FSFI), the Female Sexual Distress Scare Revised (FSDS-R), the Urinary Distress Inventory (UDI), and adverse events were collected and reported for the two-year follow-up. The changes in scores were compared between the four-week and two-year and the one-year and two-year follow-ups using paired t-tests. (3) Results: In total, 67 BC survivors were enrolled, 59 completed treatments and the four week follow-up, 39 participated in the one-year follow-up, and 33 participated in the two-year follow-up. After initial improvement in the VAS from baseline to the four week follow-up, there was no statistically significant difference in the VAS score (mean Δ 0.23; 95% CI [−0.05, 0.51], p = 0.150) between the four week follow-up and the two-year follow-up. At the two-year follow-up, the FSFI and FSDS-R scores remained improved from baseline and there was no statistically significant change in the FSFI score (mean Δ −0.83; 95% CI [−3.07, 2.38] p = 0.794) or the FSDS-R score (mean Δ −2.85; 95% CI [−1.88, 7.59] p = 0.227) from the one to two-year follow-up. The UDI scores approached baseline at the two-year follow-up; however, the change between the one- and two-year follow-ups was not statistically significant (mean Δ 4.76; 95% CI [−1.89, 11.41], p = 0.15). (4) Conclusions: Breast cancer survivors treated with fractional CO2 laser therapy have sustained improvement in sexual function two years after treatment completion, suggesting potential long-term benefit.
Immunotherapy beyond cellular therapy in Follicular Lymphoma: A case of complete remission after failure of two CAR-T
Kase, Adam M. , Dabaja, Mohamed Kharfan, Donaldson, Andrew , Elliott, Jamie, Sher, Taimur

Mayo Clinic

No container title available | January 30, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.164356053.39116247/v1 Get It

Patients with relapsed follicular lymphoma who do not respond to CAR-T have a poor outcome. We present a case of refractory follicular lymphoma who relapsed after two CAR-T infusions and achieved a complete remission after treatment with obinutuzumab and lenalidomide. This represents a promising treatment option in the post-CAR-T setting.
“Heart in DRESS”: Cardiac Manifestations, Treatment and Outcome of Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Systematic Review
Radovanovic, Milan , Jevtic, Dorde , Calvin, Andrew D. , Petrović, Marija , Prada, Libardo Rueda , Sprecher, Lawrence J., Savić, Ivana , Dumic, Igor , Jevtic, Djordje , Paulson, Margaret, Rueda Prada, Libardo , Sprecher, Lawrence, Dumic, Igor , Calvin, Andrew D , Paulson, Margaret R.

Mayo Clinic

Journal of Clinical Medicine | January 29, 2022 | Volume: 11 | Issue: 3 | Pages: 704

10.3390/jcm11030704 | PMID 35160164 Get It

Cardiac involvement in drug reaction with eosinophilia and systemic symptoms (DS) is rare but associated with high mortality. The aim of this research was to systematically review case reports by PRISMA guidelines in order to synthetize the knowledge of cardiac manifestations of DS. We identified 42 cases from 36 case reports. Women were two times more affected than men. Two-thirds of patients had cardiac manifestation in the initial phase of the disease, while in one-third of cases cardiac manifestations developed later (mean time of 70 ± 63 days). The most common inciting medications were minocycline (19%) and allopurinol (12%). In 17% of patients, the heart was the only internal organ affected, while the majority (83%) had at least one additional organ involved, most commonly the liver and the kidneys. Dyspnea (55%), cardiogenic shock (43%), chest pain (38%), and tachycardia (33%) were the most common cardiac signs and symptoms reported. Patients frequently had an abnormal ECG (71.4%), and a decrease in left ventricular ejection fraction was the most common echocardiographic finding (45%). Endomyocardial biopsy or histological examination at autopsy was performed in 52.4%, with the predominant finding being fulminant eosinophilic myocarditis with acute necrosis in 70% of those biopsied. All patients received immunosuppressive therapy with intravenous steroids, while non-responders were more likely to have received IVIG, cyclosporine, mycophenolate, and other steroid-sparing agents (60%). Gender and degree of left ventricular systolic dysfunction were not associated with outcomes, but short latency between drug exposure and the first DRESS symptom onset (<15 days) and older age (above 65 years) was associated with death. This underscores the potential importance of heightened awareness and early treatment.
High-impact chronic pain transition in surgical recipients with cervical spondylotic myelopathy
Cook, Chad E., George, Steven Z., Asher, Anthony L., Bisson, Erica F., Buchholz, Avery L., Bydon, Mohamad, Chan, Andrew K., Haid, Regis W., Mummaneni, Praveen V., Park, Paul, Shaffrey, Christopher I., Than, Khoi D., Tumialan, Luis M., Wang, Michael Y., Gottfried, Oren N., Park, Paul , Cook, Chad E., George, Steven Z., Asher, Anthony L., Bisson, Erica F., Buchholz, Avery L., Bydon, Mohamad, Chan, Andrew K., Haid, Regis W., Mummaneni, Praveen V., Park, Paul, Shaffrey, Christopher I., Than, Khoi D., Tumialan, Luis M., Wang, Michael Y., Gottfried, Oren N.

Mayo Clinic

Journal of Neurosurgery: Spine | January 28, 2022 | Volume: 37 | Issue: 1 | Pages: 31-40

10.3171/2021.11.spine211260 | PMID 35061992 Get It

OBJECTIVE High-impact chronic pain (HICP) is a recently proposed metric that indicates the presence of a severe and troubling pain-related condition. Surgery for cervical spondylotic myelopathy (CSM) is designed to halt disease transition independent of chronic pain status. To date, the prevalence of HICP in individuals with CSM and their HICP transition from presurgery is unexplored. The authors sought to define HICP prevalence, transition, and outcomes in patients with CSM who underwent surgery and identify predictors of these HICP transition groups. METHODS CSM surgical recipients were categorized as HICP at presurgery and 3 months if they exhibited pain that lasted 6–12 months or longer with at least one major activity restriction. HICP transition groups were categorized and evaluated for outcomes. Multivariate multinomial modeling was used to predict HICP transition categorization. RESULTS A majority (56.1%) of individuals exhibited HICP preoperatively; this value declined to 15.9% at 3 months (71.6% reduction). The presence of HICP was also reflective of other self-reported outcomes at 3 and 12 months, as most demonstrated notable improvement. Higher severity in all categories of self-reported outcomes was related to a continued HICP condition at 3 months. Both social and biological factors predicted HICP translation, with social factors being predominant in transitioning to HICP (from none preoperatively). CONCLUSIONS Many individuals who received CSM surgery changed HICP status at 3 months. In a surgical population where decisions are based on disease progression, most of the changed status went from HICP preoperatively to none at 3 months. Both social and biological risk factors predicted HICP transition assignment.
Inflammatory Cells in Nephrectomy Tissue from Patients without and with a History of Urinary Stone Disease
Dejban, Pegah, Wilson, Elena , Jayachandran, Muthuvel , Hernandez, Loren P. Herrera , Haskic, Zejfa , Wellik, Linda, Rule, Andrew D. , Đenić, Aleksandar , Koo, Kevin , Potretzke, Aaron M. , Wilson, Elena M , Herrera Hernandez, Loren P, Wellik, Linda E, Rule, Andrew D , Denic, Aleksandar , Sinha, Sutapa , Lieske, John C.

Mayo Clinic

Clinical Journal of the American Society of Nephrology | January 25, 2022 | Volume: 17 | Issue: 3 | Pages: 414-422

10.2215/cjn.11730921 | PMID 35078782 Get It

Background and objectives Urinary stone disease has been associated with inflammation, but the specific cell interactions that mediate events remain poorly defined. This study compared calcification and inflammatory cell patterns in kidney tissue from radical nephrectomy specimens of patients without and with a history of urinary stone disease. Design, setting, participants, & measurements Nontumor parenchyma of biobanked radical nephrectomy specimens from age- and sex-matched stone formers ( n =44) and nonstone formers ( n =82) were compared. Calcification was detected by Yasue staining and inflammatory cell populations by immunohistochemistry for CD68 (proinflammatory M1 macrophages), CD163 and CD206 (anti-inflammatory M2 macrophages), CD3 (T lymphocytes), and tryptase (mast cells). Calcifications and inflammatory cells were quantified in cortex and medulla using Image-Pro analysis software. Results Calcification in the medulla of stone formers was higher than in nonstone formers ( P <0.001). M1 macrophages in the cortex and medulla of stone formers were greater than in nonstone formers ( P <0.001), and greater in stone former medulla than stone former cortex ( P =0.02). There were no differences in age, sex, body mass index, tumor characteristics (size, stage, or thrombus), vascular disease status, or eGFR between the groups. M2 macrophages, T lymphocytes, and mast cells did not differ by stone former status. There was a correlation between M1 macrophages and calcification in the medulla of stone formers (rho=0.48; P =0.001) and between M2 macrophages and calcification in the medulla of nonstone formers (rho=0.35; P =0.001). T lymphocytes were correlated with calcification in the cortex of both nonstone formers (rho=0.27; P =0.01) and stone formers (rho=0.42; P =0.004), whereas mast cells and calcification were correlated only in the cortex of stone formers (rho=0.35; P =0.02). Conclusions Higher medullary calcification stimulated accumulation of proinflammatory rather than anti-inflammatory macrophages in stone formers.
Recurrence Following Endoscopic Laser Wedge Excision and Triple Medical Therapy for Idiopathic Subglottic Stenosis
Bowen, Andrew J. , Xie, Katherine , O’Byrne, Thomas J., Bayan, Semirra L. , Edell, Eric S. , Vassallo, Robert , Ekbom, Dale C. , Kasperbauer, Jan L. , Bowen, Andrew Jay , Xie, Katherine Z , Vassallo, Robert , Bayan, Semirra

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 25, 2022 | Volume: 167 | Issue: 3 | Pages: 524-530

10.1177/01945998221074684 | PMID 35077239 Get It

ObjectiveWe present the outcomes for patients with idiopathic subglottic stenosis (iSGS) following their first carbon dioxide laser wedge excision (LWE) procedure, additionally examining the effect of compliance with adjuvant medical therapy (triple therapy) after the operation.Study DesignRetrospective chart review.SettingTertiary center.MethodsA retrospective review was performed on 183 patients with iSGS following their first LWE and their compliance to adjuvant medical therapy (inhaled corticosteroid, proton pump inhibitor, trimethoprim‐sulfamethoxazole) following the operation, with all reviewed to December 31, 2020. The primary outcome variable was median time to recurrence (MTR). Patients were stratified by whether the LWE was their first operation (LWE primary or secondary), by compliance to triple therapy, and by compliance with trimethoprim‐sulfamethoxazole. Kaplan‐Meier analysis and Cox proportional hazards were used to evaluate the MTR across the stratifications.ResultsAn overall 113 patients underwent their first LWE, while 70 received the procedure after having undergone 1 to 13 procedures. The MTR between LWE primary and secondary was 4.6 and 2.9 years, respectively. Adjusted Cox proportional hazards comparing these 2 groups revealed the number of prior operations to be a confounding variable. A statistically increased MTR was demonstrated with greater degrees of medical compliance.ConclusionLWE conferred an MTR of 4.1 years in the iSGS cohort. The number of prior procedures preceding LWE behaved as a confounding variable. Patients who were completely or partially compliant to triple therapy appear to demonstrate increased intervals prior to recurrence.